FIELD: medicine.
SUBSTANCE: invention refers to pharmaceutical industry, particularly a preparation that is able to suppress an immune response underlying immunoglobulin-E-dependent allergic diseases. Application of water-soluble polysaccharides made of clover (Trifolium pretense L.), as a preparation able to suppress the immune response underlying immunoglobulin-E- dependent allergic diseases.
EFFECT: polysaccharides made of clover (Trifolium pretense L) exhibit effective antiallergic activity and affect the earliest stages of formation of Th2-dependent allergic reactions associated with development of immunoglobulins E and G1.
3 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIALLERGIC AGENT | 2008 |
|
RU2378004C1 |
AGENT OF ANTIALLERGIC ACTION | 2007 |
|
RU2337699C1 |
AGENT BASED ON WATER-SOLUBLE VEGETABLE POLYSACCHARIDES, HAVING ANTIALLERGIC ACTIVITY | 2023 |
|
RU2823873C1 |
AGENT ELICITING ANTI-ALLERGIC EFFECT | 2003 |
|
RU2240801C1 |
IMMUNOMODULATORY DRUG | 2010 |
|
RU2421232C1 |
PRODUCT OF HUMIC NATURE WITH ANTI-ALLERGIC ACTIVITY | 2020 |
|
RU2750098C1 |
METHOD FOR PRODUCING POLARIZED LYMPHOCYTES FOR MODELING Th2-INDUCED EDEMA | 2006 |
|
RU2318525C1 |
MEDICATION POSSESSING IMMUNOMODULATING ACTIVITY | 2010 |
|
RU2423141C1 |
IMMUNOMODULATORY DRUG | 2011 |
|
RU2470656C1 |
DRUG OF HUMIC NATURE, WHICH HAS AN IMMUNOMODULATORY EFFECT | 2022 |
|
RU2783772C1 |
Authors
Dates
2010-01-20—Published
2008-06-16—Filed